AVVA RUS is going to launch two import-substituting projects

| By | Drug Manufacturing, Import Substitution

Representatives of Kirov regional Ministry of Industry and Energy visited OJSC AVVA RUS – a company that has been producing the proprietary medicinal drugs since 1996.

Olga Gordienko, Director of the company, told that AVVA RUS is getting ready to start manufacturing of a medication (broad-spectrum antibiotic) included in the List of Vital and Essential Drugs. In December 2016 the Industrial Development Fund has provided the company a loan amounting to 50 million rubles for the purchase of necessary equipment.

AVVA RUS is going to launch two import-substituting projects aimed at production of pharmaceutical substances designated for manufacturing of medicinal drugs.

Production of active pharmaceutical ingredients based on materials of animal origin is unique for Russian pharmaceutical industry. Such substances have not been produced in Russia yet. Implementation of these projects will result in the drug price decline and will allow new and innovative drugs produced domestically enter the Russian market.